37025-59-5 Usage
Uses
Used in Pharmaceutical Industry:
(IR,2S)-I-N,N-Diethylnorephedrine HCL is used as a nasal decongestant for treating nasal congestion. Its application is based on its ability to target adrenergic receptors in the respiratory tract, which leads to the relaxation of smooth muscles and reduction of nasal congestion.
(IR,2S)-I-N,N-Diethylnorephedrine HCL is also used as a bronchodilator to alleviate respiratory issues. (IR,2S)-I-N,N-Diethylnorephedrine HCL works by targeting the same adrenergic receptors, promoting the relaxation of smooth muscles in the respiratory tract and improving airflow.
Potential Application in Obesity Treatment:
(IR,2S)-I-N,N-Diethylnorephedrine HCL may be used as a potential treatment for obesity due to its stimulant properties. However, further research and clinical trials are necessary to establish its efficacy and safety in this context.
Potential Application as a Stimulant:
(IR,2S)-I-N,N-Diethylnorephedrine HCL could be utilized as a stimulant for various purposes, such as increasing alertness or addressing certain medical conditions. However, its use in this regard is strictly regulated due to the potential for abuse and side effects, including increased heart rate and elevated blood pressure.
Check Digit Verification of cas no
The CAS Registry Mumber 37025-59-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 3,7,0,2 and 5 respectively; the second part has 2 digits, 5 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 37025-59:
(7*3)+(6*7)+(5*0)+(4*2)+(3*5)+(2*5)+(1*9)=105
105 % 10 = 5
So 37025-59-5 is a valid CAS Registry Number.
37025-59-5Relevant academic research and scientific papers
THE STEREOSELECTIVE REDUCTION OF α-AMINOPROPIOPHENONE DERIVATIVES WITH SODIUM BOROHYDRIDE
Kametani, Tetsuji,Kigasawa, Kazuo,Hiiragi, Mineharu,Wagatsuma, Nagatoshi,Kohagizawa, Toshitaka,Inoue, Hitoshi
, p. 775 - 778 (2007/10/02)
The ratio of erythro and threo products from the sodium borohydride reduction of the hydrochlorides, and other acid salts, of α-aminopropiophenone derivatives was determined.It was found that this procedure resulted in stereoselective formation of erythro-2-amino-1-phenylpropanols in contrast to sodium borohydride reduction of the corresponding free bases.The method was successfully applied to the synthesis of dl-erythro-2-(4-benzylpiperidino)-1-(4-hydroxyphenyl)propanol which has been used as a vasodilator.
